Business Services
Pharmaceutical Business Services – News, analysis and company profiles
MHRA Grants Conditional Marketing Authorisation in Great Britain to CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Haemophilia B
March 27, 2023 Business Services
This medicine is subject to additional monitoring.This will allow quick identification of new safety information.
Avacta to present pre-clinical data on AVA3996 at the American Association for Cancer Research Annual Meeting
March 27, 2023 Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces it will …
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
March 27, 2023 Business Services
Leiden, The Netherlands, March 24, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the …
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023 Business Services
NEW YORK and BERLIN, March 24, 2023 (GLOBE NEWSWIRE) — atai Life Sciences&
Announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology Demonstrates significant reduction of nasal S. aureus in preoperative cardiac surgery patients
March 24, 2023 Business Services
Brighton, United Kingdom – 24 March 2023 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the …
NICE publishes guidance recommending Bayer’s Kerendia® (finerenone) as an option for treating adult patients with chronic kidney disease associated with type 2 diabetes
March 23, 2023 Business Services
Reading, 23rd March 2023 – Today, the National Institute for Health and Care Excellence (NICE) has published a new guidance …
SYMBICORT (budesonide/formoterol) TURBOHALER 200/6 APPROVED AS FIRST AND ONLY COMBINATION RELIEVER FOR MILD ASTHMA IN THE UK
March 23, 2023 Business Services
London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …
BIAL appoints Max Bricchi as Chief Commercial Officer
March 23, 2023 Business Services
BIAL has announced the appointment of Max Bricchi as Chief Commercial Officer (CCO) and Executive Board member. With responsibility for …
Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting
March 23, 2023 Business Services
Tokyo, Japan and Cambridge, UK, 23 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
March 22, 2023 Business Services
VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have …
Hadassah Selects YonaLink’s EHR-to-EDC Clinical Trial Platform to Securely and Seamlessly Integrate Clinical Care and Research Data
March 22, 2023 Business Services
Boston, March 22, 2023 — YonaLink, a clinical trial software provider, today announced its EHR-to-EDC data integration platform has been …
Bio-Rad Launches PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers
March 22, 2023 Business Services
HERCULES, Calif. — March 15, 2023 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science …
InvoX Pharma’s F-star announces licence agreement with Takeda for second novel next-generation immuno-oncology bispecific antibody
March 22, 2023 Business Services
LONDON, United Kingdom, March, 22, 2023 (GLOBE NEWSWIRE): InvoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited …
Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression
March 22, 2023 Business Services
Boston, Massachusetts March 22, 2023 – Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify …
ELLAB LAUNCHES NEW MONITORING SOLUTION FOR LIFE-SAVING PRODUCTS
March 22, 2023 Business Services
Ellab has launched a new continuous monitoring solution for the biotech and pharmaceutical sectors, which accurately monitors critical processes 24/7. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
